
    
      Systemic consolidation therapy with paclitaxel plus carboplatin (3 cycles per 3 weeks)
      following radical hysterectomy and adjuvant chemoradiation (3 cycles per 3 weeks) for high
      risk early stage cervical cancer will elevate the therapeutic efficacy by removing the
      microscopic metastatic lesions which could not be identified by naked eye and diagnostic
      imaging tests.
    
  